Many modern drugs are manufactured by hardworking cells, but this presents special challenges.
“Biotech is about accepting that the unit of production is the living cell,” said Robert Bradway, president of biotech Amgen, to a room of manufacturing business leaders on the MIT campus today.
Comments are closed.